Stockreport

Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF – First and only investigational medicine for this rare, often fatal neurological condition –– On track to submit new drug application (NDA) in Q1 2026 – CARLSBAD, Ca [Read more]